08 Aug Kincell Bio
Bruce Thompson, Ph.D., CEO
Oct. 12 | 11:45pm | Ecolab Life Sciences Ballroom
Kincell Bio is an early-stage cell therapy partner providing contract development and manufacturing (CDMO) services for innovator biotech and academic spinout companies. Our focus is on helping companies identify their key value propositions, develop their product CMC strategy, and then execute on it. This is accomplished through CMC consulting, guidance to build an appropriate Target Product Profile (TPP) to support the desired clinical POC and then support for process and analytical development, IND-enabling activities and cGMP manufacturing for Phase 1/2 clinical trials. In addition to longstanding collective expertise in the early development of autologous cell therapies, our team brings a strong culture of collaboration and innovation. With connections across the industry and an ecosystem of partner companies (e.g., plasmid DNA, viral vector, CMC and Facility consultants, etc), we can quickly identify opportunities to develop client programs and technologies into mature processes and analytical methods to support hypothesis driven clinical investigation.